Month: October 2024

CytoMed Therapeutics’ first-in-human Phase I ANGELICA clinical trial using its patented donor allogeneic chimeric antigen receptor T cell (CAR-T cell) against blood and solid tumors received co-funding support from the NMRC Clinical Trial Grant

Celly Nutrition Signs a Master Distribution Agreement with FUSION Distribution Group across Puerto Rico, The Caribbean, and parts of Central and South America.

Vancouver, British Columbia--(Newsfile Corp. - October 7, 2024) - Celly Nutrition Corp. ("Celly Nu" or the "Company"), led by CEO...

error: Content is protected !!